# A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma

> **NCT07201064** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Guangdong ProCapZoom Biosciences Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DRUG:** SZ1003 injection

## Key facts

- **NCT ID:** NCT07201064
- **Lead sponsor:** Guangdong ProCapZoom Biosciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-25
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07201064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07201064, "A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07201064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*